Skip to main content
ARQT
NASDAQ Life Sciences

Arcutis Sinks ~20% as Q3 Earnings Miss on Surging SG&A, Guidance Still Raised

Tom Rudovsky · Reported by Seeking Alpha
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$26.96
Mkt Cap
$3.389B
52W Low
$19.295
52W High
$34.8
52W Position info
40% above low
Off High info
23% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

ARQT sits 40% above its 52-week low of $19.295.

Summary

Arcutis dropped nearly 20% Thursday after Q3 GAAP EPS of $0.06 missed consensus by $0.10, even though revenue of $143.9M beat by $1.3M and rose 45% year over year. The miss was expense-driven: net income of $8.8M came in well below the $20.7M analysts projected as R&D and SG&A climbed roughly 14% and 60% year over year to $22.4M and $99.6M, both above consensus. Management pinned the SG&A jump on its celebrity awareness campaign and a sales force expansion. Offsetting that, the company raised full-year net product sales guidance to $535M-$545M from $525M-$540M, implying about 45% growth at the midpoint and $156M-$166M for Q4. Analysts at Needham and Jefferies kept Buy ratings and $40/$39 targets, citing Zoryve demand and the new PCP/peds salesforce as drivers into 2027.

At the time of this announcement, ARQT was trading at $26.96 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.4B. The 52-week trading range was $19.30 to $34.80. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.


Price Chart

Share this article

Copied!

ARQT - Latest Insights

ARQT
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $29.00
Real-time Price: $27.15 info
Change: -$1.85 (-6%) info
Market Cap: $3.436B info
ARQT
Nov 04, 2026, 4:04 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $31.25
Real-time Price: $27.15 info
Change: -$4.10 (-13%) info
Market Cap: $3.436B info
ARQT
Nov 04, 2026, 4:02 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $32.30
Real-time Price: $27.15 info
Change: -$5.15 (-16%) info
Market Cap: $3.436B info
ARQT
Nov 04, 2026, 4:00 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $34.23
Real-time Price: $27.15 info
Change: -$7.08 (-21%) info
Market Cap: $3.436B info
ARQT
Aug 20, 2026, 1:38 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $24.92
Real-time Price: $27.15 info
Change: +$2.23 (+9%) info
Market Cap: $3.436B info